Treatment of advanced levodopa-responsive Parkinson's disease with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of Parkinson medicinal products have not given satisfactory results.
Treatment of advanced Parkinson's disease with severe motor fluctuations and hyperkinesia or dyskinesia when available oral combinations of Parkinson medicinal products have not given satisfactory results.
The results were announced from a Phase III trial evaluating the levodopa-carbidopa intestinal gel (LCIG) from Abbott Labs for advanced...
Studies evaluating levodopa-carbidopa intestinal gel (LCIG), from Abbott, in patients with advanced Parkinson's Disease show positive effects in a long-term...
Feldene Gel is a non-steroidal anti-inflammatory agent indicated for a variety of conditions characterised by pain and inflammation, or stiffness. It is effective in the treatment of osteoarthritis of superficial joints such as the knee, acute musculoskeletal injuries, periarthritis, epicondylitis, tendinitis and tenosynovitis.